An Open-Label Pilot Study of Qualia Senolytic Supplementation for the Attenuation of Systemic Inflammatory Cytokines
Trial registry update: NOT_YET_RECRUITING. No results reported in the supplied registry record.
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: May 1, 2025 · Discovered: Sep 16, 2026 · Assessed: — · Historical research backfill
What it does not prove
- This is a protocol description without reported outcomes; it does not demonstrate that the intervention had any effect on inflammatory cytokines
- Open-label design with no control group means any observed changes cannot be distinguished from placebo or natural variation
- A 7-day duration is too short to establish whether any acute changes persist or translate to meaningful health benefits
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Other
- Sample size
- —
- Duration
- —
- Population
- Adults aged 45 to 79 residing in the United States
- Primary outcome
- Systemic inflammatory cytokines
- Effect size
- —
- Significance
- Not reported
- Journal
- Qualia Life Sciences
- Published
- May 1, 2025
Funding: Not reported. Journal is published by Qualia Life Sciences, the apparent manufacturer of the intervention product.
Conflicts: Not disclosed. The journal and study appear to be sponsored or conducted by the company manufacturing the intervention.
Sources
Primary source
- Qualia Life Sciences ↗Clinical trial
Recorded source passages
Abstract or registry material supplied for assessment; source version 1. This is not a claim of full-text review.
This open-label pilot study includes adults aged 45 to 79 residing in the United States. The study will last 7 days.
Participants will provide blood samples via an at-home finger-prick kit at baseline and day 7 and complete electronic surveys on health indicators at baseline, and days 3 and 7.
All procedures are conducted remotely, with no in-person visits, to collect real-world evidence.
Source versions
Assessment history
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
No comments yet
Be the first to weigh in on this evidence.